## **THE LONDON WOMEN’S CLINIC FOUNDATION** 

## **Trustees Report and Financial Statements** 

**Year ended: 30[th] September 2023** 

**Charity Number: 1134485** 

_**THE LONDON WOMEN’S CLINIC FOUNDATION**_ 



## **REFERENCE AND ADMINISTRATIVE INFORMATION** 

## **Trustees** 

Dr Kamal Ahuja – Chair of Trustees 

Dr Shailjah Nair 

Mrs Mimi Arian-Schad 

## **Principal Office** 

113-115 Harley Street, London W1G 6AP 

## **Charity Number** 

1134485 

## **Auditors** 

Cheesmans, 4 Aztec Row, Berners Road, London N1 0PW 

## **Bankers** 

HSBC, 1-3 Bishopgate, London, EC2N 3AQ 

## **Solicitors** 

William Sturges & Co, Burwood House, 14-16 Caxton Street, London SW1H 0QY 

## **REPORT OF THE TRSUTEES FOR THE YEAR ENDED 30[TH] SEPTEMBER 2023** 

The trustees present their annual report and financial statements for the charity for the year ended 30[th] September 2023.  The financial statements have been produced in accordance with the requirements of the Charities Act 2011.  This is supported by the enclosed independent examiners report of the London Women’s Clinic Foundation. 

## **STRUCTURE, GOVERANCE AND MANAGEMENT** 

The Foundation is a registered charity, number 1134485, and is constituted under a trust dated 27[th] November 2009.  The foundation was established by an initial gift from the London Women’s Clinic.  The Foundation does not actively fundraise and seeks to continue the charitable work through gifts from the London Women’s Clinic and other corporate bodies. 

_**THE LONDON WOMEN’S CLINIC FOUNDATION**_ 



At the annual general meeting, the trustees agree the broad strategy and areas of activity for the Foundation.  The day-to-day administration of grants, and the processing and handling of applications is delegated to the Chairman. 

All trustees give their time freely and no trustees renumeration was paid in the year. 

## **AIMS AND OBJECTIVES** 

The aims and objectives of the Foundation are as follows. 

- 1) To advance education for the public benefit, in particular but not exclusively, in the fields of reproductive medicine and fertility and the natural and earth sciences, in the United Kingdom in such ways as the charity thinks fit, including by: - 

   - a) Awarding scholarships, maintenance allowances or grants tenable at any university, college, or institute of higher or further education. 

   - b) Funding participation at scientific conferences 

   - c) Promoting research for the public benefit and publishing the useful results thereof. 

- 2) The prevention of and relief of poverty in developing nations by: - 

   - a) Providing grants, items and services to individuals in need and/or charities, or other organisations working to prevent or relieve poverty. 

   - b) Promoting research for the public benefit into the factors that contribute to poverty and the most appropriate ways of mitigating these, including research into the welfare of children in developing nations. 

The trustees confirmed that they have referred to the Foundation’s aims and objectives in planning future activities and setting the grant making policy for the year. 

## **A REVIEW OF ACHIEVEMENTS AND PERFORMANCE** 

The trustees are pleased that the achievements and performance of the Foundation, as set out below, demonstrate concrete progress. 

## **Donations:** 

The Foundation has made the following donations during the year ended 30[th] September 2023: - 

Royal College of Music 

St John’s College, Oxford University Donor Conception Network Origins of Aneuploidy Research Consortium Fertility Research & Development Fund 

## **Education Project** 

The Foundation continued to be involved in the funding of educational projects whose aim was to advance education to the public benefit.  During the year the Foundation continued the Harley Street Concerts to 

_**THE LONDON WOMEN’S CLINIC FOUNDATION**_ 



present a platform for music students to perform for the local community living and working near Harley Street, Marylebone, London. 

The main contributions this year were for scholarships at Royal College of Music. 

## **TRUSTEES’ RESPONSIBILITIES IN RELATION TO THE FINACIAL STATEMENTS** 

The trustees are responsible for preparing the Trustees’ Report and the financial statements in accordance with the applicable law and the United Kingdom Accounting Standards.  The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of the affairs of the charity for that period.  In preparing these financial statements, the trustees are required to: 

- Select suitable accounting policies and apply them consistently. 

- Observe the methods and principles of the Charities Statement of Recommended Practice 

- Make judgements and estimates that are reasonable and prudent 

- State whether applicable accounting standards have been followed, subject to any departures disclosed and explained in the financial statements, and 

- Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. 

The trustees are responsible for keeping accounting records which disclose with reasonable accuracy the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 1973, the Charity (Accounts and Reports) Regulations 2008 and the provision of the trust deed. They are responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities. 

Approved by the trustees on 25 July 2024 and signed on their behalf by: 


------------------------------ 

## **Dr Kamal Ahuja** 

## **CHAIR OF TRUSTEES** 

_**THE LONDON WOMEN’S CLINIC FOUNDATION**_ 



||**THE LONDON WOMEN'S CLINIC FOUNDATION**<br>|**THE LONDON WOMEN'S CLINIC FOUNDATION**<br>|**THE LONDON WOMEN'S CLINIC FOUNDATION**<br>|**THE LONDON WOMEN'S CLINIC FOUNDATION**<br>|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|10/1/2022|**To**|9/30/2023||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**<br>Donation/legacies/grants<br>**42,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**42,000**<br>**-**<br>**-**<br>**_Sub total_                              -**<br>**_Total receipts_                 42,000**<br>**A3 Payments**<br>Grants and donationspaid<br>**38,500**<br>Subcontractor expenses<br>Bank charges<br>**95**<br>Sundryexpenses<br>**173**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                     38,768**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total payments_                 38,768**<br>**_Net of receipts/(payments)_                   3,232**<br>**A5 Transfers between funds**<br>**-                 3,608**<br>**A6 Cash funds last year end**<br>**3,215**<br>**_Cash funds this year end_                   2,839**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**||**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**20,818**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**20,818**<br>**-**<br>**-**<br>**-**<br>**20,818**<br>**-               20,818**<br>**3,608**<br>**17,210**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**42,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**42,000**<br>**-**<br>**-**<br>**-**<br>**42,000**<br>**59,318**<br>**-**<br>**95**<br>**173**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**59,586**<br>**-**<br>**-**<br>**-**<br>**59,586**<br>**-               17,586**<br>**-**<br>**20,425**<br>**2,839**|**Last year**<br>**to the nearest £**|
||||**-**|**42,000**|**62,500**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**42,000**|**62,500**|
|||||||
||||**-**|**-**||
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
|||||||
||||**-**|**42,000**|**62,500**|
|||||||
||||**-**|**59,318**|**36,739**|
||||**-**|**-**|**5,290**|
||||**-**|**95**|**46**|
||||**-**|**173**|**383**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**59,586**|**42,458**|
|||||||
||||**-**|**-**||
||||**-**|**-**||
||||**-**|**-**|**-**|
|||||||
||||**-**|**59,586**|**42,458**|
|||||||
|||**-               20,818**|**-**|**-               17,586**|**20,042**|
|||**3,608**|**-**|**-**|**-**|
|||**17,210**|**-**|**20,425**|**383**|
|||**-**|**-**|**2,839**|**20,425**|





|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|---|
|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**|**Details**<br>Bank<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**2,839**<br>**-**<br>**-**<br>**2,839**<br>OK<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Unrestricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**|**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||OK|
|||||**to nearest £**<br>**Endowment**<br>**funds**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**When due**<br>**(optional)**|
||||**-**||
||||**-**||
||||**-**||
||||**-**||
||||**-**||



Signed by one or two trustees on behalf of all the trustees 

|Signature|Print Name<br>Dr K Ahuja|Date of<br>approval|
|---|---|---|
||Dr K Ahuja|23-Jul|
||||





||**THE LONDON WOMEN'S CLINIC FOUNDATION**<br>|**THE LONDON WOMEN'S CLINIC FOUNDATION**<br>|**THE LONDON WOMEN'S CLINIC FOUNDATION**<br>|**THE LONDON WOMEN'S CLINIC FOUNDATION**<br>|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|10/1/2022|**To**|9/30/2023||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**<br>Donation/legacies/grants<br>**42,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**42,000**<br>**-**<br>**-**<br>**_Sub total_                              -**<br>**_Total receipts_                 42,000**<br>**A3 Payments**<br>Grants and donationspaid<br>**38,500**<br>Subcontractor expenses<br>Bank charges<br>**95**<br>Sundryexpenses<br>**173**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                     38,768**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total payments_                 38,768**<br>**_Net of receipts/(payments)_                   3,232**<br>**A5 Transfers between funds**<br>**-                 3,608**<br>**A6 Cash funds last year end**<br>**3,215**<br>**_Cash funds this year end_                   2,839**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**||**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**20,818**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**20,818**<br>**-**<br>**-**<br>**-**<br>**20,818**<br>**-               20,818**<br>**3,608**<br>**17,210**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**42,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**42,000**<br>**-**<br>**-**<br>**-**<br>**42,000**<br>**59,318**<br>**-**<br>**95**<br>**173**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**59,586**<br>**-**<br>**-**<br>**-**<br>**59,586**<br>**-               17,586**<br>**-**<br>**20,425**<br>**2,839**|**Last year**<br>**to the nearest £**|
||||**-**|**42,000**|**62,500**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**42,000**|**62,500**|
|||||||
||||**-**|**-**||
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
|||||||
||||**-**|**42,000**|**62,500**|
|||||||
||||**-**|**59,318**|**36,739**|
||||**-**|**-**|**5,290**|
||||**-**|**95**|**46**|
||||**-**|**173**|**383**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**59,586**|**42,458**|
|||||||
||||**-**|**-**||
||||**-**|**-**||
||||**-**|**-**|**-**|
|||||||
||||**-**|**59,586**|**42,458**|
|||||||
|||**-               20,818**|**-**|**-               17,586**|**20,042**|
|||**3,608**|**-**|**-**|**-**|
|||**17,210**|**-**|**20,425**|**383**|
|||**-**|**-**|**2,839**|**20,425**|





|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|---|
|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**|**Details**<br>Bank<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**2,839**<br>**-**<br>**-**<br>**2,839**<br>OK<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Unrestricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**|**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||OK|
|||||**to nearest £**<br>**Endowment**<br>**funds**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**When due**<br>**(optional)**|
||||**-**||
||||**-**||
||||**-**||
||||**-**||
||||**-**||



Signed by one or two trustees on behalf of all the trustees 

|Signature|Print Name<br>Dr K Ahuja|Date of<br>approval|
|---|---|---|
||Dr K Ahuja|23-Jul|
||||



